Senior executive responsible for leading and originating strategic transactions for Catalent, Inc. (NYSE: CTLT), the leading provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products. Responsible for global M&A strategy, execution and strategic alliances. Mike is a member of Catalent’s Executive Leadership Team.